Effects of pregabalin on sleep in generalized anxiety disorder
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Sleep disturbance is a cardinal symptom in both DSM-IV and ICD-10 criteria for generalized anxiety disorder (GAD). This review summarizes the results of clinical trials and pooled analyses that provide data on pregabalin's effect on sleep disturbance in patients diagnosed with GAD. The hypothesized mechanism of action of pregabalin is distinctly different from other anxiolytics. Pregabalin binds to a membrane α2δ subunit protein to inhibit release in excited central nervous system neurons of neurotransmitters implicated in pathological anxiety. Treatment with pregabalin has been found to be associated with significant improvement in GAD-related sleep disturbance across seven placebo-controlled clinical trials. Treatment with pregabalin is associated with improvement in all forms of insomnia and improvement in sleep has been found to be correlated with reduction in functional impairment and improvement in quality of life on subjective global measures. Results of a mediational analysis suggest that 53% of the effect of pregabalin on sleep disturbance was due to a direct effect and 47% was due to an indirect effect, mediated through prior reduction in anxiety symptom severity. In patients with GAD, improvement in sleep has been found to be associated with a reduction in daytime sleepiness. However, dose-related sedation is reported, typically in the first 2 wk of treatment, in approximately 10–30% of patients, depending on the dose used and the speed of titration. Insomnia is a common component of the clinical presentation of GAD and pregabalin appears to be an efficacious treatment for this often chronic and disabling symptom.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology of insomnia: what we know and what we still need to learn
Ohayon, M. M. (2002) · Sleep Medicine Reviews · doi:10.1053/smrv.2002.0186 · Cited by 3,743
Sleep disturbance and psychiatric disorders: A longitudinal epidemiological study of young Adults
Breslau, N., Roth, T., Rosenthal, L., & Andreski, P. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00188-3 · Cited by 1,831 · cited 4×
“The results of several longitudinal studies indicate that insomnia, either as a symptom or a diagnosis, typically precedes the onset of MDD, frequently by>1 yr, with onset of insomnia associated with a 4-fold increased risk of developing a subsequent episode of MDD (Breslau et al. 1996; Chang et al. 1997; Eaton et al.…”
BackgroundInfluentialEpidemiology of Insomnia, Depression, and Anxiety
Taylor, D. J., Lichstein, K. L., Durrence, H. H., Reidel, B. W., & Bush, A. J. (2005) · Sleep · doi:10.1093/sleep/28.11.1457 · Cited by 988 · cited 1×
“Insomnia and major depressive disorder (MDD) have a high level of co-morbidity ; the presence of insomnia is associated with a significantly higher likelihood of having a GAD diagnosis when compared to patients who do not report insomnia (Breslau et al. 1996; Johnson et al. 2006; Taylor et al. 2005).”
BackgroundMorin, C. M., & Jarrin, D. C. (2022) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2022.03.003 · Cited by 907
Place of chronic insomnia in the course of depressive and anxiety disorders
Ohayon, M. M., & Roth, T. (2003) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(02)00052-3 · Cited by 873
Johnson, E. O., Roth, T., & Breslau, N. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.07.008 · Cited by 804 · cited 5×
“Insomnia and major depressive disorder (MDD) have a high level of co-morbidity ; the presence of insomnia is associated with a significantly higher likelihood of having a GAD diagnosis when compared to patients who do not report insomnia (Breslau et al. 1996; Johnson et al. 2006; Taylor et al. 2005).”
BackgroundMethodInfluentialPsychometric properties of the Medical Outcomes Study Sleep measure
Hays, R. D., Martin, S. A., Sesti, A. M., & Spritzer, K. L. (2005) · Sleep Medicine · doi:10.1016/j.sleep.2004.07.006 · Cited by 557
Insomnia and the Performance of US Workers: Results from the America Insomnia Survey
Kessler, R. C., Berglund, P. A., Coulouvrat, C., Hajak, G., Roth, T., Shahly, V., Shillington, A. C., Stephenson, J. J., & Walsh, J. K. (2011) · Sleep · doi:10.5665/sleep.1230 · Cited by 527
The morbidity of insomnia uncomplicated by psychiatric disorders
Weissman, M. M., Greenwald, S., Niño-Murcia, G., & Dement, W. C. (1997) · General Hospital Psychiatry · doi:10.1016/s0163-8343(97)00056-x · Cited by 415 · cited 2×
“The results of several longitudinal studies indicate that insomnia, either as a symptom or a diagnosis, typically precedes the onset of MDD, frequently by>1 yr, with onset of insomnia associated with a 4-fold increased risk of developing a subsequent episode of MDD (Breslau et al. 1996; Chang et al. 1997; Eaton et al.…”
BackgroundSleep disturbance in generalized anxiety disorder and its treatment
Monti, J. M., & Monti, D. (2000) · Sleep Medicine Reviews · doi:10.1053/smrv.1999.0096 · Cited by 223
Cited by
Morin, C. M., Drake, C. L., Harvey, A. G., Krystal, A. D., Manber, R., Riemann, D., & Spiegelhalder, K. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.26 · Cited by 746
Baldwin, D. S., Anderson, I. M., Nutt, D. J., Allgulander, C., Bandelow, B., den Boer, J. A., Christmas, D. M., Davies, S., Fineberg, N., Lidbetter, N., et al. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114525674 · Cited by 676
“In generalised anxiety disorder, it is efficacious in relieving depressive symptoms of mild to moderate intensity [I (M)] (Stein et al., 2008a), and in reducing the severity of sleep disturbance (Holsboer-Trachsler and Prieto, 2013).”
BackgroundDrugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery
Atkin, T., Comai, S., & Gobbi, G. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014381 · Cited by 391
The assessment and management of insomnia: an update
Krystal, A. D., Prather, A. A., & Ashbrook, L. H. (2019) · World Psychiatry · doi:10.1002/wps.20674 · Cited by 256
Neuroscience-driven discovery and development of sleep therapeutics
Dresler, M., Spoormaker, V. I., Beitinger, P., Czisch, M., Kimura, M., Steiger, A., & Holsboer, F. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.10.012 · Cited by 63
Metadata
- Authors
- Holsboer-Trachsler, E., & Prieto, R.
- Venue
- International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-05-01
- Volume
- 16
- Issue
- 4
- Pages
- 925-936
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- OpenAlex
- W2103125926
- Cited by
- 53
- References
- 13
- FWCI
- 6.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of pregabalin on sleep in generalized anxiety disorder. https://app.cochat.ai/papers/10.1017/s1461145712000922
- The paper
- Holsboer-Trachsler, E., & Prieto, R. (2013). Effects of pregabalin on sleep in generalized anxiety disorder. International Journal of Neuropsychopharmacology. https://doi.org/10.1017/s1461145712000922
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.